Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS?
Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
Pathological differences between white and grey matter multiple sclerosis lesions.
Loss of Mobility and the Patient Burden of Multiple Sclerosis: Expert Opinion on Relevance to Daily Clinical Practice.
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Early detection of thrombin activity in neuroinflammatory disease.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
[Diagnosis and monitoring of multiple sclerosis : The value of optical coherence tomography.]
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Pages
« first
‹ previous
…
552
553
554
555
556
557
558
559
560
…
next ›
last »